The autoantibody profiles of the patients studied
| Autoantibodies | CHB+ study cohort (n=16) | CHB− control cohort (n=65) | p Value |
|---|---|---|---|
| Autoantibodies n (%) | |||
| Ro52+Ro60 | 16 (100) | 53 (81.5) | 0.11 |
| Ro52+La | 13 (81.3) | 44 (67.7) | 0.37 |
| Ro60+La | 13 (81.3) | 48 (73.8) | 0.75 |
| Ro52+Ro60+La | 13 (81.3) | 44 (67.7) | 0.37 |
| p200+Ro52+Ro60 | 15 (93.8) | 42 (64.6) | 0.03* |
| p200+La | 13 (81.3) | 40 (61.5) | 0.24 |
| p200+Ro52+Ro60+La | 13 (81.3) | 39 (60) | 0.15 |
*Statistically significant difference.
CHB+, congenital heart block outcome; CHB−, normal pregnancy outcome.